Pfizer Stock News

In the two months since the approval of child-sized doses of Pfizers COVID-19 vaccine, only 51 per cent of children in that age group have had at least one dose

BioNTech (BNTX) stock is rising higher on news it and Pfizer (PFE) can test a new Covid-19 vaccine for Omicron in adults.

BioNTech (BNTX), the German partner of Pfizer (PFE) in COVID-19 vaccine development, says that their plans to manufacture an Omicron-specific vaccine will be subject to how much…

"Indefensible Edict" - DeSantis Rages After Biden''s FDA Restricts Use Of Monoclonal Antibody Treatments Governor Ron DeSantis is demanding the Biden Administration reverse its sudden decision to revoke emergency use authorization (EUA) for monoclonal antibody treatments. In a statement from the Florida Governor''s office , he rages that this abrupt and unilateral action by the Biden Administration will prevent access to lifesaving treatments for Floridians and Americans. Without a shred of clinical data to support this action, Biden has forced trained medical professionals to choose between treating their patients or breaking the law, said Governor Ron DeSantis. This indefensible edict takes treatment out of the hands of medical professionals and will cost some Americans their lives. There are real-world implications to Bidens medical authoritarianism Americans access to treatments is now subject to the whims of a failing president. Rather than giving Americans the option for various COVID treatments, the FDA and the Biden Administration issued their royal decree, taking away the very thing that is proven to reduce hospitalizations and save lives, said Lieutenant Governor Jeanette Nuñez. Monoclonal antibody treatments like Regeneron have had a positive impact for thousands of Floridians.

The study will measure the safety and effectiveness of a vaccine specifically tailored to the Omicron variant in adults ages 18 to 55.

Pfizer and BioNTech are testing an omicron-specific form of the COVID-19 vaccine to see if it has more durable protection against coronavirus infection. The original shot still holds against severe disease.

Pfizer Inc (NYSE: Full story available on Benzinga.com

The drugmakers said the study will evaluate the safety and immune response of the new inoculation in up to 1,420 healthy adults ages 18 through 55.

Pfizer (PFE) and BioNTech (BNTX) announced that the first patient was enrolled in their trial for the Omicron-based vaccine candidate.The study designed to test the vaccine as a

Pfizer has begun a study comparing its original COVID-19 vaccine with doses specially tweaked to match the omicron variant

Its COVID pill is practically guaranteed to be the biggest story.

Drug manufacturing giant Pfizer -- which generated an industry shattering $80 billion in business last year thanks largely to sales of its coronavirus vaccine -- is sticking charter school kids in Brooklyn with an injection of rejection, school officials said.

A booster dose of AstraZeneca (AZN), Pfizer (PFE)/ BioNTech (BNTX), and Johnson & Johnson (JNJ) vaccines led to a significant increase in COVID-19 antibody levels in those who

Pfizer stock tumbled Monday after the FDA rejected its OPKO Health-partnered treatment for growth hormone deficiency.

Anixa Biosciences (ANIX) has added ~6.5% in the pre-market after announcing that in early lab studies, a molecule developed by the company and partner MolGenie GmbH was more potent…